CIDINITAB 20

Description

Cilnidipine 20 mg CIDINITAB 20 contains Cilnidipine 20 mg, a modern calcium channel blocker (CCB) belonging to the dihydropyridine class of antihypertensive medications. Cilnidipine is unique because it blocks both L-type and N-type calcium channels, which helps relax blood vessels while also reducing excessive sympathetic nerve activity. This dual mechanism not only lowers blood pressure effectively but also minimizes side effects like rapid heartbeat, which are often associated with other calcium channel blockers. By improving blood circulation, reducing vascular resistance, and protecting organs from damage caused by high blood pressure, CIDINITAB 20 offers a comprehensive approach to managing hypertension. Uses of CIDINITAB 20 CIDINITAB 20 is mainly prescribed for the treatment and management of: Hypertension (High Blood Pressure): Effectively reduces elevated blood pressure and prevents complications. Cardiovascular Risk Reduction: Helps lower the chances of stroke, heart attack, and heart failure. Kidney Protection: Especially beneficial in patients with hypertension and diabetes, as it reduces kidney strain. Prevention of Organ Damage: Helps protect vital organs such as the brain, kidneys, and heart from damage due to long-term high blood pressure. Side Effects of CIDINITAB 20 Like all medicines, CIDINITAB 20 may cause some side effects, although not everyone experiences them. Common Side Effects: Headache Flushing (warmth or redness of the face) Dizziness or lightheadedness Swelling of ankles or feet (peripheral edema) Fatigue or weakness Rare but Serious Side Effects: Low blood pressure (hypotension) Irregular heartbeat or palpitations Liver function abnormalities Allergic reactions such as rash, itching, or swelling Shortness of breath in sensitive patients Seek medical attention immediately if serious side effects occur. Precautions Before Using CIDINITAB 20 Do not take if you are allergic to Cilnidipine or other calcium channel blockers. Use with caution in patients with severe liver disease. Patients with a history of heart failure or cardiac conduction issues should take it only under medical supervision. Avoid in pregnancy and breastfeeding, unless clearly prescribed by the doctor. Do not stop taking this medication suddenly, as it can cause a sudden spike in blood pressure. Limit alcohol intake since it can enhance dizziness and low blood pressure. Drug Interactions of CIDINITAB 20 Other antihypertensives (beta-blockers, ACE inhibitors, ARBs): May cause excessive lowering of blood pressure. CYP3A4 inhibitors (ketoconazole, itraconazole, erythromycin): Increase the level of Cilnidipine in the body. CYP3A4 inducers (rifampicin, phenytoin, carbamazepine): May reduce the effectiveness of the drug. Alcohol: Enhances dizziness and low blood pressure effects. Grapefruit juice: May alter drug metabolism and should be avoided. Conclusion CIDINITAB 20 (Cilnidipine 20 mg Tablets) is a modern and highly effective antihypertensive medicine that offers dual calcium channel blocking action for comprehensive blood pressure control. It not only reduces blood pressure but also protects vital organs, minimizes reflex tachycardia, and provides additional benefits in patients with diabetes-related hypertension and kidney disease. By ensuring steady blood pressure control and protecting the heart, kidneys, and brain, CIDINITAB 20 is a trusted choice for long-term hypertension management. Patients benefit from its unique dual mechanism, improved tolerability, and protective effects, making it a reliable treatment option in modern cardiovascular care.